Rapport Therapeutics, Inc. (RAPP)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch RAPP
Latest sale
$87k
Sep 23 · Routine
Form 4 sales
42
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

3
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Jul 14 2026

    Sold 8,210 shares at $40.00 ($328k)

    Ceesay Abraham, Chief Executive Officer

    10b5-1 planSold 1.5% of holdings ($21.9M position)539,817 shares left0.8x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Jul 27 +13 days

    Sold 2,210 shares at $42.11 ($93k)

    Ceesay Abraham, Chief Executive Officer

    10b5-1 planSold 0.4% of holdings ($22.7M position)537,607 shares left0.2x usual sizeFiling

  3. 3 Form 4 saleUnusual
    Aug 11 +15 days

    Sold 51,499 shares at $47.24 ($2.4M)

    Ceesay Abraham, Chief Executive Officer

    10b5-1 planSold 9.6% of holdings ($25.4M position)486,108 shares left4.7x usual sizeFiling

  4. 4 Form 4 saleRoutine
    Aug 19 +8 days

    Sold 404 shares at $49.90 ($20k)

    Yeleswaram Krishnaswamy, Chief Development Officer

    10b5-1 planSold 0.2% of holdings ($12.3M position)246,022 shares left0x usual sizeFiling

  5. 5 Form 4 saleUnusual
    Aug 25 +6 days

    Sold 50,160 shares at $50.47 ($2.5M)

    Yeleswaram Krishnaswamy, Chief Development Officer

    10b5-1 planSold 20.4% of holdings ($12.4M position)195,862 shares left7.7x usual sizeFiling

  6. 6 Form 4 saleRoutine
    Aug 25 same day

    Sold 18,921 shares at $49.57 ($938k)

    Ceesay Abraham, Chief Executive Officer

    10b5-1 planSold 3.9% of holdings ($24.1M position)467,187 shares left1.7x usual sizeFiling

  7. 7 Form 4 saleRoutine
    Sep 8 +14 days

    Sold 8,210 shares at $45.62 ($375k)

    Ceesay Abraham, Chief Executive Officer

    10b5-1 planSold 1.8% of holdings ($21.3M position)458,977 shares left0.8x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Sep 23 +15 days

    Sold 2,210 shares at $39.17 ($87k)

    Ceesay Abraham, Chief Executive Officer

    10b5-1 planSold 0.5% of holdings ($18M position)456,767 shares left0.2x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (42)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for RAPP
Source
Sep 23, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale2,210$87k0.5%RoutineSEC
Sep 8, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale8,210$375k1.8%RoutineSEC
Aug 25, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale18,921$938k3.9%RoutineSEC
Aug 25, 2026Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale50,160$2.5M20.4%UnusualSEC
Aug 19, 2026Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale404$20k0.2%RoutineSEC
Aug 11, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale51,499$2.4M9.6%UnusualSEC
Jul 27, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale2,210$93k0.4%RoutineSEC
Jul 14, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale8,210$328k1.5%RoutineSEC
Jun 30, 2026Gault CherylChief Operating OfficerForm 4 sale10,000$416k6.3%RoutineSEC
Jun 29, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale8,220$327k1.5%RoutineSEC
May 26, 2026Third Rock Ventures V, L.P.10% ownerForm 4 sale18,572$744k0.3%RoutineSEC
May 11, 2026Third Rock Ventures V, L.P.10% ownerForm 4 sale133,618$5.4M2.1%RoutineSEC
May 8, 2026Third Rock Ventures VI, L.P.10% ownerForm 4 sale276,513$11.1M4.1%RoutineSEC
Apr 17, 2026Third Rock Ventures VI, L.P.10% ownerForm 4 sale426,005$17.2M6.0%RoutineSEC
Apr 17, 2026Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale20,225$809k7.6%UnusualSEC
Apr 14, 2026Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale19,865$696k6.9%UnusualSEC
Apr 8, 2026Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale360$13k0.1%RoutineSEC
Mar 30, 2026Gault CherylChief Operating OfficerForm 4 sale10,000$282k5.9%RoutineSEC
Mar 25, 2026Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale10,115$303k3.4%RoutineSEC
Mar 5, 2026Gault CherylChief Operating OfficerForm 4 sale2,014$58k1.2%No planSEC
Feb 18, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale10,916$320k1.9%RoutineSEC
Feb 17, 2026Bredt DavidChief Scientific OfficerForm 4 sale8,500$247k2.1%RoutineSEC
Jan 20, 2026Ceesay AbrahamChief Executive OfficerForm 4 sale10,916$285k1.9%RoutineSEC
Jan 15, 2026Bredt DavidChief Scientific OfficerForm 4 sale8,500$228k2.1%RoutineSEC
Dec 31, 2025Bredt DavidChief Scientific OfficerForm 4 sale6,567$197k1.6%No planSEC
Dec 31, 2025Yeleswaram KrishnaswamyChief Development OfficerForm 4 sale2,840$85k0.9%No planSEC
Dec 17, 2025Ceesay AbrahamChief Executive OfficerForm 4 sale10,916$324k1.9%RoutineSEC
Dec 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$255k2.1%RoutineSEC
Nov 26, 2025Gault CherylChief Operating OfficerForm 4 sale5,000$151k2.8%RoutineSEC
Nov 17, 2025Ceesay AbrahamChief Executive OfficerForm 4 sale10,916$275k1.9%RoutineSEC
Nov 17, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$214k2.1%RoutineSEC
Oct 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$219k2.0%RoutineSEC
Oct 15, 2025Ceesay AbrahamChief Executive OfficerForm 4 sale10,916$282k1.8%RoutineSEC
Sep 17, 2025Ceesay AbrahamChief Executive OfficerForm 4 sale76,420$2M11.5%RoutineSEC
Sep 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$206k2.0%RoutineSEC
Sep 8, 2025Gault CherylChief Operating OfficerForm 4 sale5,000$192k2.8%RoutineSEC
Aug 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$127k2.0%RoutineSEC
Jul 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$119k1.9%RoutineSEC
Jun 16, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$94k1.9%RoutineSEC
May 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$81k1.8%RoutineSEC
Apr 15, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$81k1.8%RoutineSEC
Mar 14, 2025Bredt DavidChief Scientific OfficerForm 4 sale8,500$92k1.8%RoutineSEC